For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Health Catalyst Inc (NASDAQ: HCAT) closed at $3.97 in the last session, down -2.46% from day before closing price of $4.07. In other words, the price has decreased by -$2.46 from its previous closing price. On the day, 0.89 million shares were traded.
Ratios:
We take a closer look at HCAT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 1.42. In the meantime, Its Debt-to-Equity ratio is 1.10 whereas as Long-Term Debt/Eq ratio is at 0.46.
On January 08, 2025, KeyBanc Capital Markets Upgraded its rating to Overweight which previously was Sector Weight but kept the price unchanged to $9.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 05 ’25 when LeSueur Daniel sold 5,209 shares for $4.10 per share. The transaction valued at 21,331 led to the insider holds 205,832 shares of the business.
LeSueur Daniel sold 5,209 shares of HCAT for $21,604 on Apr 03 ’25. The Chief Operating Officer now owns 211,041 shares after completing the transaction at $4.15 per share. On Apr 03 ’25, another insider, DANIEL LESUEUR, who serves as the Officer of the company, bought 10,418 shares for $4.45 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.90 while its Price-to-Book (P/B) ratio in mrq is 0.70.
Stock Price History:
Over the past 52 weeks, HCAT has reached a high of $9.24, while it has fallen to a 52-week low of $3.56. The 50-Day Moving Average of the stock is -5.36%, while the 200-Day Moving Average is calculated to be -39.01%.
Shares Statistics:
A total of 69.59M shares are outstanding, with a floating share count of 66.36M. Insiders hold about 4.64% of the company’s shares, while institutions hold 77.46% stake in the company.
